Monoclonal Antibody

Antibodies In-Depth Focus 2019

11 September 2019 | By Drug Target Review

The articles in this antibodies In-Depth Focus assess the methods used to develop antibody therapeutics and the evolution of this area of medicine to identify drug targets.

Streptococcal toxic shock syndrome vaccine candidate developed

4 September 2019 | By Victoria Rees (Drug Target Review)

Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.

Application note: Rapidly isolate high-producing clones

21 December 2018 | By Sphere Fluidics Ltd.

Find out how to streamline Cell Line Development by identifying high-producing clones with monoclonality assurance in one day.

Sphere Fluidics Ltd.

Antibodies In-Depth Focus 2018

6 September 2018 | By Drug Target Review

In this In-Depth Focus, Stefan R. Schmidt discusses the current status and future perspectives of monoclonal antibodies and Tony Edge explains why the determination of aggregate is critical in the formation of monoclonal antibodies.

Targeting BAFF reduces the development of atherosclerosis

18 June 2018 | By Drug Target Review

The researchers identified that BAFF to have anti-inflammatory properties, which has a positive effect on plaque size and atherosclerosis...

Kymab appoints Dr Sonia Quaratino as Chief Medical Officer

11 May 2017 | By Niamh Marriott (Drug Target Review)

Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.